BackSecond Sight Medical Products Overview

Second Sight Medical Products Current Assets

Latest current assets for EYES: $22M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$21.64M
148.25% YoYΔ $12.92M vs prior year quarter

Peer trimmed avg / median

Loading

Second Sight Medical Products Current Assets History

Loading

Second Sight Medical Products vs. peers: Current Assets Comparison

Loading

Second Sight Medical Products Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Second Sight Medical Products (EYES) FAQ

As of the most recent data (June 2026), EYES shows a current assets of $22M. That compares with $8.7M in the prior-year period — up 148.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EYES's current assets is now $22M (was $8.7M) — a 148.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Second Sight Medical Products is outperforming or lagging.

Tracking EYES's current assets over time shows whether Second Sight Medical Products is scaling, shrinking, or reshaping that part of the business. The current reading is $22M That compares with $8.7M in the prior-year period — up 148.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Second Sight Medical Products's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $22M) with ownership activity and broader fundamentals.

Second Sight Medical Products's current assets is $22M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.